GRAIL Financials - Benzinga

GRAIL Inc

GRALNASDAQ

Trade with Public

Trade with Public

$80.34

-0.28-0.35%

At close: Sep 4, 5:00 PM EST

$80.51

0.170.21%

After Hours: 7:37 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

GRAIL Financials

GRAIL (GRAL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate

GRAIL (NASDAQ:GRAL) reported quarterly losses of $(2.56) per share which beat the analyst consensus estimate of $(2.62) by 1.92 percent. This is a 19.5 percent increase over losses of $(3.18) per share from the same

Benzinga Newsdesk

PRO
GRAIL Q1 EPS $(2.29) Beats $(2.70) Estimate, Sales $39.832M Beat $38.881M Estimate

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Stock Market Today: Dow Jones, S&P 500 Futures Slip After Weaker-Than-Expected GDP Report—Grail, Candel Therapeutics, Copart In Focus (UPDATED)

(Editor's note: The future prices of benchmark tracking ETFs, the lede, and the headline were updated in the story. Figures from economic reports were added.) U.S. stock futures declined on Friday following the release of key economic data. Futures of all the major benchmark indices ticked lower.

Rishabh Mishra

Why Grail Stock Is Sinking Friday

GRAIL (NASDAQ: GRAL) shares plunged after the NHS-Galleri trial failed to meet its primary endpoint. Explore the trial results.

Vandana Singh

GRAIL: Q4 Earnings Insights

Benzinga Insights